ArticleAmerican journal of hematology2026

Response to Methodological Concerns Regarding Eligibility Criteria and Study Selection in a Systematic Review and Meta-Analysis of CAR T-Cell Therapy for Hematologic Malignancies.

Charalampos Filippatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.